This year’s WIRED Health summit in Boston featured Moderna CEO Stéphane Bancel, CNN chief medical correspondent Sanjay Gupta, ...

ZUG, Switzerland and BOSTON and SAN DIEGO and SHANGHAI, Sept. 22, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP) ...

Genetic editing holds promise to treat incurable diseases, but the most popular method—CRISPR—sometimes does more harm than ...

Genetic editing holds promise to treat incurable diseases, but the most popular method - CRISPR - sometimes does more harm ...

Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing ...

Abstract Triggering cancer cell death by inducing DNA damage is the primary aim of radiotherapy; however, normal cells are also damaged. In this ...

By knocking out a protein duo’s “bodyguard” role, researchers have exposed a hidden weakness in pancreatic cancer. It’s a ...

UNIVERSITY CITY (WPVI) -- The first attempt in the United States to use a gene-editing tool called CRISPR against cancer seems safe in the three patients who have had it so far, but it's too soon to ...

CRISPR Therapeutics AG (NASDAQ: CRSP) is one of the best emerging technology stocks to buy right now. On September 3, Bank of ...

A CRISPR system detects rare cancer mutations in blood with single-nucleotide precision, outperforming ddPCR through engineered RNA guides and isothermal amplification. (Nanowerk Spotlight) Hidden ...

Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced ...